All Stories

  1. Broad-acting antivirals: the pursuit of pan-viral therapeutics in the era of pandemics

    Article • Journal of Virology, March 2026, ASM Journals

    Dr Ilya Gordeychuk

  2. Efficacy of Plasmid DNA Delivery into Mice by Intradermal Injections Alone and Facilitated by Sonoporation or Electroporation

    Article • Vaccines, January 2026, MDPI AG

    Dr Ilya Gordeychuk

  3. Novel Multistage Subunit Mycobacterium tuberculosis Nanoparticle Vaccine Confers Protection Against Experimental Infection in Prophylactic and Therapeutic Regimens

    Article • Vaccines, December 2025, MDPI AG

    Dr Ilya Gordeychuk

  4. Neutralising and Non-neutralising Antibodies to SARS-CoV-2: Role during Infection and in the Evolution of Antigenic structure

    Article • Epidemiology and Vaccinal Prevention, January 2025, LLC Numicom

    Dr Ilya Gordeychuk

  5. Immunotherapeutic Potential of the Yellow Fever Virus Vaccine Strain 17D for Intratumoral Therapy in a Murine Model of Pancreatic Cancer

    Article • Vaccines, January 2025, MDPI AG

    Dr Ilya Gordeychuk

  6. Neutralizing Antibody Spectrum in COVID-19 Patients who Became Ill During the Circulation of Different SARS-CoV-2 Variants

    Article • Epidemiology and Vaccinal Prevention, November 2024, LLC Numicom

    Dr Ilya Gordeychuk

  7. Experimental Use of Common Marmosets (<i>Callithrix jacchus</i>) in Preclinical Trials of Antiviral Vaccines

    Article • Acta Naturae, August 2024, Acta Naturae Ltd

    Dr Ilya Gordeychuk

  8. A Chimeric Vaccine Based on a Single Fusion Protein (W-PreS-O) Combining RBDs from Wuhan hu-1 Wild Type and Omicron Shows Protective Effect against Omicron Infection in Syrian Hamsters

    Article • May 2024, MDPI AG

    Dr Ilya Gordeychuk

  9. Swelling, Rupture and Endosomal Escape of Biological Nanoparticles Per Se and Those Fused with Liposomes in Acidic Environment

    Article • Pharmaceutics, May 2024, MDPI AG

    Alessandro Parodi, Dr Ilya Gordeychuk

  10. Swelling, Rupture and Endosomal Escape of Biological Nanoparticles per se and Those Fused with Liposomes in Acidic Environment

    Article • April 2024, MDPI AG

    Dr Ilya Gordeychuk

  11. Correction: Zhitkevich et al. HIV-1 Reverse Transcriptase Expression in HPV16-Infected Epidermoid Carcinoma Cells Alters E6 Expression and Cellular Metabolism, and Induces a Hybrid Epithelial/Mesenchymal Cell Phenotype. Viruses 2024, 16, 193

    Article • Viruses, April 2024, MDPI AG

    Dr Ilya Gordeychuk

  12. HIV-1 Reverse Transcriptase Expression in HPV16-Infected Epidermoid Carcinoma Cells Alters E6 Expression and Cellular Metabolism, and Induces a Hybrid Epithelial/Mesenchymal Cell Phenotype

    Article • Viruses, January 2024, MDPI AG

    Dr Ilya Gordeychuk

  13. Expressed in HPV 16 Infected Epidermoid Carcinoma Cells, HIV‐1 Reverse Transcriptase Shifts Their Metabolism towards aerobic Glycolysis, Induces Hybrid E/M Cell Phenotype and Increases Expression of E6 Transcripts

    Article • December 2023, MDPI AG

    Dr Ilya Gordeychuk

  14. Safety and Immunogenicity of Inactivated Whole Virion COVID-19 Vaccine CoviVac in Clinical Trials in 18–60 and 60+ Age Cohorts

    Article • Viruses, August 2023, MDPI AG

    Dr Ilya Gordeychuk

  15. Common Marmoset Cell Lines and Their Applications in Biomedical Research

    Article • Cells, August 2023, MDPI AG

    Dr Ilya Gordeychuk

  16. The informative value of noninvasive tools for assessment of liver fibrosis in chronic hepatitis B patients under antiviral treatment with nucleoside and nucleotide analogues

    Article • Almanac of Clinical Medicine, August 2023, Moscow Regional Research and Clinical Institute (MONIKI)

    Dr Ilya Gordeychuk

  17. Predictors of treatment efficacy with nucleos(t)ide analogues for chronic hepatitis B

    Article • Experimental and Clinical Gastroenterology, July 2023, LLC Global Media Technology

    Dr Ilya Gordeychuk

  18. Transient and tunable CRISPRa regulation of APOBEC/AID genes for targeting hepatitis B virus

    Article • Molecular Therapy — Nucleic Acids, June 2023, Elsevier

    Dr Ilya Gordeychuk

  19. Clinical and virological characteristics of chronic hepatitis b and response to antiviral therapy

    Article • March 2023, Federal Medical Biological Agency

    Dr Ilya Gordeychuk

  20. Depleting hepatitis B virus relaxed circular DNA is necessary for resolution of infection by CRISPR-Cas9

    Article • Molecular Therapy — Nucleic Acids, March 2023, Elsevier

    Dr Ilya Gordeychuk

  21. Hydroxychloroquine Enhances Cytotoxic Properties of Extracellular Vesicles and Extracellular Vesicle–Mimetic Nanovesicles Loaded with Chemotherapeutics

    Article • Pharmaceutics, February 2023, MDPI AG

    Alessandro Parodi, Dr Ilya Gordeychuk

  22. HIV-1 Protease as DNA Immunogen against Drug Resistance in HIV-1 Infection: DNA Immunization with Drug Resistant HIV-1 Protease Protects Mice from Challenge with Protease-Expressing Cells

    Article • Cancers, December 2022, MDPI AG

    Dr Ilya Gordeychuk

  23. Geographic and Temporal Variability of Hepatitis E Virus Circulation in the Russian Federation

    Article • Viruses, December 2022, MDPI AG

    Dr Ilya Gordeychuk

  24. Hydroxychloroquine Enhances Cytotoxic Properties of Extracellular Vesicles and Extracellular Vesicle-Mimetic Nanovesicles Loaded with Chemotherapeutics

    Article • December 2022, MDPI AG

    Alessandro Parodi, Dr Ilya Gordeychuk

  25. Geographic and Temporal Variability of Hepatitis E Virus Circulation in Non-Endemic Territories

    Article • November 2022, MDPI AG

    Dr Ilya Gordeychuk

  26. Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates

    Article • Emerging Microbes & Infections, September 2022, Taylor & Francis

    Dr Ilya Gordeychuk

  27. Vaccination With Oral Polio Vaccine Reduces COVID-19 Incidence

    Article • Frontiers in Immunology, May 2022, Frontiers

    Dr Ilya Gordeychuk

  28. Hepatitis B, C and TTV virus infection in highly trained athletes

    Article • March 2022, Federal Medical Biological Agency

    Dr Ilya Gordeychuk

  29. Immunization with recombinant ORF2 p551 protein protects common marmosets (Callithrix jacchus) against homologous and heterologous hepatitis E virus challenge

    Article • Vaccine, January 2022, Elsevier

    Dr Ilya Gordeychuk

  30. Immunity and Viral Infections: Modulating Antiviral Response via CRISPR–Cas Systems

    Article • Viruses, July 2021, MDPI AG

    Dr Ilya Gordeychuk

  31. Cellular Immune Response Induced by DNA Immunization of Mice with Drug Resistant Integrases of HIV-1 Clade A Offers Partial Protection against Growth and Metastatic Activity of Integrase-Expressing Adenocarcinoma Cells

    Article • Microorganisms, June 2021, MDPI AG

    Dr Ilya Gordeychuk

  32. Reciprocal Inhibition of Immunogenic Performance in Mice of Two Potent DNA Immunogens Targeting HCV-Related Liver Cancer

    Article • Microorganisms, May 2021, MDPI AG

    Dr Ilya Gordeychuk

  33. Correction: DNA immunization site determines the level of gene expression and the magnitude, but not the type of the induced immune response

    Article • PLOS One, February 2021, PLOS

    Dr Ilya Gordeychuk

  34. Corrigendum to isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak [Int. J. Infect. Dis. 99 (2020) 40-46]

    Article • International Journal of Infectious Diseases, February 2021, Elsevier

    Dr Ilya Gordeychuk

  35. Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies

    Article • Emerging Microbes & Infections, January 2021, Taylor & Francis

    Dr Ilya Gordeychuk

  36. Preclinical studies of immunogenity, protectivity, and safety of the combined vector vaccine for prevention of the middle east respiratory syndrome

    Article • Acta Naturae, October 2020, Acta Naturae Ltd

    Dr Ilya Gordeychuk

  37. Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak

    Article • International Journal of Infectious Diseases, October 2020, Elsevier

    Dr Ilya Gordeychuk

  38. Expression of the Reverse Transcriptase Domain of Telomerase Reverse Transcriptase Induces Lytic Cellular Response in DNA-Immunized Mice and Limits Tumorigenic and Metastatic Potential of Murine Adenocarcinoma 4T1 Cells

    Article • Vaccines, June 2020, MDPI AG

    Dr Ilya Gordeychuk

  39. A heterologous virus-vectored vaccine for prevention of Middle East respiratory syndrome induces long protective immune response against MERS-CoV

    Article • Immunologiya, January 2020, Geotar-Media Publishing Group

    Dr Ilya Gordeychuk

  40. HIV-1 Reverse Transcriptase Promotes Tumor Growth and Metastasis Formation via ROS-Dependent Upregulation of Twist

    Article • Oxidative Medicine and Cellular Longevity, December 2019, Hindawi Publishing Corporation

    Prof. Ilze Strumfa, Alexander Komarov, Dr Ilya Gordeychuk

  41. Replenishment of Hepatitis B Virus cccDNA Pool Is Restricted by Baseline Expression of Host Restriction Factors In Vitro

    Article • Microorganisms, November 2019, MDPI AG

    Dr Ilya Gordeychuk

  42. ATM and ATR Expression Potentiates HBV Replication and Contributes to Reactivation of HBV Infection upon DNA Damage

    Article • Viruses, October 2019, MDPI AG

    Dr Ilya Gordeychuk

  43. The First Complete Genome Sequences of Hepatitis C Virus Subtype 2b from Latin America: Molecular Characterization and Phylogeographic Analysis

    Article • Viruses, October 2019, MDPI AG

    Dr Ilya Gordeychuk

  44. Therapeutic Vaccines Against Human Papilloma Viruses: Achievements and Prospects

    Article • Biochemistry (Moscow), July 2019, Pleiades Publishing Ltd

    Dr Ilya Gordeychuk

  45. Assessment of the Parameters of Adaptive Cell-Mediated Immunity in Naïve Common Marmosets (Callithrix jacchus)

    Article • Acta Naturae, December 2018, Acta Naturae Ltd

    Dr Ilya Gordeychuk

  46. DNA immunization site determines the level of gene expression and the magnitude, but not the type of the induced immune response

    Article • PLOS One, June 2018, PLOS

    Dr Ilya Gordeychuk

  47. Immunization of Domestic Ducks with Live Nonpathogenic H5N3 Influenza Virus Prevents Shedding and Transmission of Highly Pathogenic H5N1 Virus to Chickens

    Article • Viruses, March 2018, MDPI AG

    Dr Ilya Gordeychuk

  48. The Evaluation of Pharmacodynamics and Pharmacokinetics of Anti-thrombin DNA Aptamer RA-36

    Article • Frontiers in Pharmacology, December 2017, Frontiers

    Dr Ilya Gordeychuk

  49. Impact of Universal Hepatitis B Vaccination on Prevalence, Infection-Associated Morbidity and Mortality, and Circulation of Immune Escape Variants in Russia

    Article • PLOS One, June 2016, PLOS

    Dr Ilya Gordeychuk

  50. Immunization with live nonpathogenic H5N3 duck influenza virus protects chickens against highly pathogenic H5N1 virus

    Article • Acta Virologica, January 2016, AEPress, s.r.o.

    Dr Ilya Gordeychuk

  51. P192: Hepatitis E epidemic process in Russian Federation

    Article • Journal of Viral Hepatitis, June 2015, Wiley

    Dr Ilya Gordeychuk

  52. P202: Rabbit hepatitis E virus circulation in endemic and non-endemic regions

    Article • Journal of Viral Hepatitis, June 2015, Wiley

    Dr Ilya Gordeychuk